Ryo Hatano Selected Research

Ryo Hatano Research Topics

Disease

10	Neoplasms (Cancer) 03/2021 - 10/2004
5	Malignant Mesothelioma 01/2019 - 01/2014
3	Immune System Diseases (Immune Disorders) 01/2019 - 02/2014
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2019 - 01/2019
2	Renal Insufficiency (Renal Failure) 01/2018 - 09/2004
2	Intrahepatic Cholestasis 01/2017 - 05/2015
2	Bronchiolitis 01/2016 - 04/2015
2	Bronchiolitis Obliterans Syndrome 01/2016 - 04/2015
2	Fibrosis (Cirrhosis) 05/2015 - 04/2015
2	Inappropriate ADH Syndrome (SIADH) 01/2007 - 05/2005
2	Hyponatremia 01/2006 - 05/2005
1	Hyperglycemia 10/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Ulcerative Colitis 01/2020
1	Obesity 09/2019
1	Rheumatic Diseases (Rheumatism) 09/2019
1	Erythema 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Nephrogenic Syndrome of Inappropriate Antidiuresis 01/2018
1	Pruritus (Itching) 06/2017
1	Mesothelioma 06/2016
1	Achlorhydria (Hypochlorhydria) 01/2016
1	Experimental Arthritis 07/2015
1	Arthritis (Polyarthritis) 05/2015
1	Lymphoma (Lymphomas) 05/2014
1	Infections 12/2013
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2013
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2013
1	Necrosis 02/2013
1	Diabetic Angiopathies (Diabetic Angiopathy) 10/2010
1	Type 2 Diabetes Mellitus (MODY) 10/2010
1	Essential Hypertension 01/2007
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2007
1	Nephrogenic Diabetes Insipidus 01/2007

Drug/Important Bio-Agent (IBA)

8	Monoclonal AntibodiesIBA 03/2021 - 07/2013
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 10/2010
3	CollagenIBA 01/2016 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 02/2014 - 05/2005
3	Vasopressins (Vasopressin)IBA 01/2007 - 05/2005
3	Aquaporin 2IBA 01/2007 - 05/2005
3	Aquaporins (Water Channels)IBA 01/2007 - 05/2005
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 09/2019
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2014
2	Imiquimod (Aldara)FDA LinkGeneric 11/2019 - 01/2019
2	Biological ProductsIBA 01/2019 - 01/2019
2	EnzymesIBA 06/2017 - 08/2015
2	ezrinIBA 01/2016 - 05/2015
2	Arginine Vasopressin (Argipressin)IBA 01/2007 - 05/2005
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2007 - 05/2005
1	LecithinsIBA 10/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2021
1	Insulin (Novolin)FDA Link 10/2021
1	CyclodextrinsIBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Therapeutic UsesIBA 11/2019
1	LeptinIBA 09/2019
1	Peptides (Polypeptides)IBA 09/2019
1	Immune Checkpoint InhibitorsIBA 09/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Ubiquitin-Specific ProteasesIBA 10/2018
1	podocalyxinIBA 01/2018
1	moesinIBA 01/2018
1	Substance PIBA 06/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2017
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	LipidsIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	RoxithromycinIBA 07/2015
1	Bile Acids and Salts (Bile Acids)IBA 05/2015
1	PeriostinIBA 05/2014
1	Transcription Factors (Transcription Factor)IBA 05/2014
1	ParaffinIBA 02/2014
1	Caveolin 1IBA 02/2014
1	Formaldehyde (Formol)FDA Link 02/2014
1	Adenosine DeaminaseIBA 02/2014
1	Fibronectins (Fibronectin)IBA 02/2014
1	IntegrinsIBA 01/2014
1	Fas Ligand Protein (Fas Ligand)IBA 02/2013
1	Granzymes (Granzyme)IBA 02/2013
1	InterferonsIBA 02/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2007
1	LithiumIBA 01/2007
1	ReninIBA 01/2007
1	Pharmaceutical PreparationsIBA 01/2007
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2007

Therapy/Procedure

7	Therapeutics 03/2021 - 09/2004
1	Immunotherapy 09/2019
1	Cell Transplantation 01/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2015
1	Hematopoietic Stem Cell Transplantation 04/2015
1	Intraperitoneal Injections 07/2013